The Delhi High Court recently held that the courts cannot proceed on the premise that all Intellectual Property Rights (IPR) suits would necessarily be valued at ₹3 lakh or above, and therefore, be listed before the commercial courts [Pankaj Ravjibhai Patel trading as Rakesh Pharmaceuticals v. SSS Pharmachem Pvt Ltd].